← All trials
NCT06580717
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 15, 2024
- Primary completion
- Nov 30, 2026
- Completion date
- Nov 30, 2026
- First posted
- Aug 30, 2024
- Last posted
- Nov 8, 2024
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Yonsei UniversityLead sponsor
- Yeungnam UniversityOfficial
- Yonsei UniversityOfficial
- Keimyung UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.